Eric Lefkofsky is a social entrepreneur with a background in innovation and technological design. He has started multiple e-commerce giants and is now focused on medical research and infrastructure. His latest endeavor, Tempus, is focused on treating cancer patients. By gathering data on a larger scale its possible to get enough molecular data to guide the development of cancer treatments. Massive genome research can inform the way physicians treat patients and in the establishment of patterns and trends in patient data.
Eric Lefkofsky explains that many research institutes are sequencing genome information and gathering patient data. However, these collection efforts are not at scale when compared to the great number of people who are affected by cancer.
Gaining access to big data is one way that not-for-profits and research institutes can leverage genetic information in the development of new drugs and treatment procedures. For example, Venter Institute And IBM have determined a similar need for large-scale data when it comes to creating effective treatment procedures for complex diseases. Because of the lower costs of genetic screening and data storage, it’s important for this information base to continue to grow and develop in relation to cancer treatment.
Tempus stands out from the rest because of their broad scale objectives. Their partnerships are expected to involve medical centers, universities and research centers to get a large pool of data. This would allow for larger scale patterns to be identified and potential genetic information to lead to better clinical practices. Eric Lefkofksy compares Tempus to other ventures, in that all endeavors have a component of Big Data. Understanding how organizations leverage data collection to come up with effective solutions and strategies is an important way to get ahead when it comes to cancer related research. To know more about him click here.
Further research of this institution will provide gene sequencing tests and incorporate much needed software in the process. By establishing cumulative ways to collect patient information it will be possible to come up with better analysis and methods of incorporating findings in targeted therapies. These are some of the ways that Tempus Labs serves a need in the community to improve outcomes when treating cancer patients.